Amarpali Brar is a Nephrology physician affiliated with University of California, San Francisco. OpenAlex indexes 27 publications with 399 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
400 Parnassus Ave
San Francisco, CA 941432202
Telephone
415-353-1551Provider last certified this registry record 8 Dec 2020.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
38.2%Corticosteroid23.6%Prednisone100%Part D≥87 patientsProton pump inhibitor6.2%Omeprazole83%Pantoprazole Sodium17%Part D<11 patients+ 4 more classes in this area
Cardiovascular
22%Calcium channel blocker7.3%Amlodipine Besylate75%Nifedipine Er25%Part D<11 patientsAngiotensin receptor blocker (ARB)4.8%Losartan Potassium100%Part D≥14 patients+ 5 more classes in this area
Anti-infectives
21%Short-acting sulfonamides8.8%Sulfamethoxazole-Trimethoprim100%Part D≥37 patientsCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor6%Valganciclovir Hcl100%Part D≥33 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Isatuximab Monotherapy for Desensitization in Highly Sensitized Patients Awaiting Kidney Transplant
Journal of the American Society of Nephrology
2023 - Association of Physical Function and Survival in Older-Adult Renal Transplant Recipients
Transplantation Proceedings
2020 - Impact of gender and gender disparities in patients with kidney disease
Current Opinion in Nephrology & Hypertension
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Kristine Yaffe, MD
University of California, San Francisco
Peter Carroll, MD
University of California, San Francisco
Mitchel Berger, MD
University of California, San Francisco
Elyse Foster, MD
University of California, San Francisco
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”